Clinical Trials Browser

Terminated × Prostatic Neoplasms × saracatinib × Clear all

NCT01267266 2015-04-01

Saracatinib in Treating Patients With Prostate Cancer

Phase 2 Terminated

31 enrolled 6 charts

Prostatic Neoplasms